NEMO, S.A. Company Profile

21:46 EDT 23rd June 2018 | BioPortfolio

Nemo es una empresa española ubicada en Cataluña (Baix Penedès) líder en la fabricación de componentes plásticos para la Industria Farmacéutica. Especializada en la inyección de plásticos, nuestra empresa se caracteriza por su capacidad de desarrollar dispositivos médicos según los requisitos de cada cliente. De hecho, es capaz de llevar a cabo con éxito el desarrollo de un producto, desde la idea original hasta los moldes de producción.Nemo is a Spanish company located in Catalonia (Baix Penedès), which holds a leading position in the manufacture of plastic components for the Pharmaceutical Industry. Specializing in plastic injection moulding, Nemo distinguishes itself by its capacity of developing drug delivery systems according to client requirements, from the very first idea to the production tools. Nemo is an ISO 9001/2000 certified company, following the GMP Guidelines and whose production process is carried out in Class D 100.000 and Class C 10.000 Clean Rooms. Some of its key products .


Avenida del Foix, s/nParque Industrial El Foix


Phone: 34 977 16 75 26
Fax: 34 977 16 75 23

News Articles [2 Associated News Articles listed on BioPortfolio]

Low Sperm Count: Here Are Some Health Problems That Could Be The Cause – Forbes

ForbesLow Sperm Count: Here Are Some Health Problems That Could Be The CauseForbesSperm count dropping? A study presented today at ENDO 2018 shows some possible causes. (Photo: Shutterstock). Dori in ...

CorWave is Set to Receive about $3.5 Million in Financing Through France’s Worldwide Innovation Challenge for Its NovaPulse Program, a Mini-Invasive Solution for Cardiac Support

CorWave, a French medical technology company that develops innovative implanted cardiac support devices for patients suffering from heart failure, announced today that it h...

Drugs and Medications [0 Results]


PubMed Articles [11 Associated PubMed Articles listed on BioPortfolio]

NEMO Links Nuclear Factor-κB to Human Diseases.

The nuclear factor (NF)-κB essential modulator (NEMO) is a key regulator in NF-κB-mediated signaling. By transmitting extracellular or intracellular signals, NEMO can control NF-κB-regulated genes....

MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner.

Mitochondrial antiviral-signaling protein (MAVS) transmits signals from RIG-I-like receptors after RNA virus infections. However, the mechanism by which MAVS activates downstream components, such as T...

IKBKG (NEMO) 5' untranslated splice mutations lead to severe, chronic disseminated mycobacterial infections.

4 patients with adult-onset, disseminated mycobacterial infection had 5' UTR mutations in IKBKG without clear physical stigmata of NEMO deficiency. These mutations caused decreased levels of NEMO prot...

Identification and functional characterization of NEMO in Crassostrea gigas reveals its crucial role in the NF-κB activation.

NEMO (NF-κB essential modulator) is one of the important regulatory subunits of the IκB kinase (IκK) complex that controls the activation of the NF-κB signaling pathway. Here, we have identified t...

Search for Neutrinoless Quadruple-β Decay of ^{150}Nd with the NEMO-3 Detector.

We report the results of a first experimental search for lepton number violation by four units in the neutrinoless quadruple-β decay of ^{150}Nd using a total exposure of 0.19 kg yr recorded with th...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube

The aim of this study is to verify the safety and accuracy of an FDA-approved device called the NEMO™ Gauge to aide in the proper positioning of the endotracheal tube inserted in the lun...

Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

This study investigates gene abnormalities in Primary Immune Deficiency(PID) with a goal of improving the diagnosis and treatment of patients. The specific disorders include: 1....

Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)

The Department of Psychiatry at the University of Pittsburgh is conducting a research study to help us learn about the changes that occur in the brain when individuals suffer from and then...

Companies [2 Associated Companies listed on BioPortfolio]


Nemo es una empresa española ubicada en Cataluña (Baix Penedès) líder en la fabricación de componentes plásticos para la Industria Farmacéutica. Especializada en la inyección d...

Teradyne, Inc.

Teradyne was founded by Alex d'Arbeloff and Nick DeWolf, two classmates who met at Massachusetts Institute of Technology (MIT) in the late 1940s when they lined up alphabetically in an ROTC class. Aft...

More Information about "NEMO, S.A." on BioPortfolio

We have published hundreds of NEMO, S.A. news stories on BioPortfolio along with dozens of NEMO, S.A. Clinical Trials and PubMed Articles about NEMO, S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NEMO, S.A. Companies in our database. You can also find out about relevant NEMO, S.A. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record